{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:03:08Z","timestamp":1776776588051,"version":"3.51.2"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"38","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,11]]},"DOI":"10.1093\/eurheartj\/ehac410","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:49:29Z","timestamp":1665064169000},"page":"3792-3793","source":"Crossref","is-referenced-by-count":7,"title":["Aldosterone excess and cardiorenal risk: more common than appreciated"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-1267","authenticated-orcid":false,"given":"George L","family":"Bakris","sequence":"first","affiliation":[{"name":"Department of Medicine, AHA Comprehensive Hypertension Center, University of Chicago Medicine , 5841 S. Maryland Ave. MC 1027, Chicago, IL 60637 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Jaisser","sequence":"additional","affiliation":[{"name":"INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Sorbonne Universit\u00e9, Universit\u00e9 de Paris, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"2022101415405133300_ehac410-B1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/M20-4873","article-title":"Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans: a retrospective cohort study","volume":"174","author":"Cohen","year":"2021","journal-title":"Ann Intern Med"},{"key":"2022101415405133300_ehac410-B2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.semnephrol.2014.04.009","article-title":"Increased aldosterone: mechanism of hypertension in obesity","volume":"34","author":"Flynn","year":"2014","journal-title":"Semin Nephrol"},{"key":"2022101415405133300_ehac410-B3","doi-asserted-by":"crossref","first-page":"e001153","DOI":"10.1136\/bmjdrc-2019-001153","article-title":"Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma","volume":"8","author":"Er","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2022101415405133300_ehac410-B4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41581-021-00490-8","article-title":"Mineralocorticoid receptor antagonists in diabetic kidney disease\u2014mechanistic and therapeutic effects","volume":"18","author":"Barrera-Chimal","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"2022101415405133300_ehac410-B5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-physiol-060821-013950","article-title":"Roles of mineralocorticoid receptors in cardiovascular and cardiorenal diseases","volume":"84","author":"Barrera-Chimal","year":"2022","journal-title":"Annu Rev Physiol"},{"key":"2022101415405133300_ehac410-B6","article-title":"Aldosterone and kidney outcomes in individuals with CKD","volume":"43","author":"Verma","year":"2022","journal-title":"Eur Heart J"},{"key":"2022101415405133300_ehac410-B7","doi-asserted-by":"crossref","first-page":"e022975","DOI":"10.1161\/JAHA.121.022975","article-title":"enhanced thrombotic responses are associated with striatin deficiency and aldosterone","volume":"10","author":"Gromotowicz-Poplawska","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2022101415405133300_ehac410-B8","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1210\/en.2006-0826","article-title":"Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects","volume":"147","author":"Funder","year":"2006","journal-title":"Endocrinology"},{"key":"2022101415405133300_ehac410-B9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0022-4731(80)90271-X","article-title":"Mediating events in the action of aldosterone","volume":"12","author":"Edelman","year":"1980","journal-title":"J Steroid Biochem"},{"key":"2022101415405133300_ehac410-B10","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/0002-9149(93)90238-8","article-title":"Aldosterone and antialdosterone therapy in congestive heart failure","volume":"71","author":"Weber","year":"1993","journal-title":"Am J Cardiol"},{"key":"2022101415405133300_ehac410-B11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2003.10.009","article-title":"Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies","volume":"217","author":"Pitt","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2022101415405133300_ehac410-B12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"2022101415405133300_ehac410-B13","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1111\/bph.15747","article-title":"Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease","volume":"179","author":"Kintscher","year":"2022","journal-title":"Br J Pharmacol"},{"key":"2022101415405133300_ehac410-B14","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Eng J Med"},{"key":"2022101415405133300_ehac410-B15","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"2022101415405133300_ehac410-B16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/38\/3792\/46535396\/ehac410.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/38\/3792\/46535396\/ehac410.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T21:26:14Z","timestamp":1665782774000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/38\/3792\/6652650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":16,"journal-issue":{"issue":"38","published-online":{"date-parts":[[2022,8,1]]},"published-print":{"date-parts":[[2022,10,11]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac410","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,7]]},"published":{"date-parts":[[2022,8,1]]}}}